Latency reversal and viral clearance to cure HIV-1.

Published

Journal Article (Review)

Research toward a cure for human immunodeficiency virus type 1 (HIV-1) infection has joined prevention and treatment efforts in the global public health agenda. A major approach to HIV eradication envisions antiretroviral suppression, paired with targeted therapies to enforce the expression of viral antigen from quiescent HIV-1 genomes, and immunotherapies to clear latent infection. These strategies are targeted to lead to viral eradication--a cure for AIDS. Paired testing of latency reversal and clearance strategies has begun, but additional obstacles to HIV eradication may emerge. Nevertheless, there is reason for optimism that advances in long-acting antiretroviral therapy and HIV prevention strategies will contribute to efforts in HIV cure research and that the implementation of these efforts will synergize to markedly blunt the effect of the HIV pandemic on society.

Full Text

Duke Authors

Cited Authors

  • Margolis, DM; Garcia, JV; Hazuda, DJ; Haynes, BF

Published Date

  • July 22, 2016

Published In

Volume / Issue

  • 353 / 6297

Start / End Page

  • aaf6517 -

PubMed ID

  • 27463679

Pubmed Central ID

  • 27463679

Electronic International Standard Serial Number (EISSN)

  • 1095-9203

Digital Object Identifier (DOI)

  • 10.1126/science.aaf6517

Language

  • eng

Conference Location

  • United States